Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Bernstein Sticks to Its Buy Rating for UnitedHealth (UNH)

Tipranks - Tipranks - Sat Apr 11, 6:02AM CDT

In a report released today, Lance Wilkes from Bernstein maintained a Buy rating on UnitedHealth, with a price target of $411.00.

Easter Sale - 70% Off TipRanks

According to TipRanks, Wilkes is an analyst with an average return of -8.7% and a 32.67% success rate. Wilkes covers the Healthcare sector, focusing on stocks such as Centene, Cigna, and HCA Healthcare.

In addition to Bernstein, UnitedHealth also received a Buy from Wells Fargo’s Stephen Baxter in a report issued on April 7. However, on April 8, TipRanks – Anthropic reiterated a Hold rating on UnitedHealth (NYSE: UNH).

See Insiders’ Hot Stocks on TipRanks >>

Based on UnitedHealth’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $113.22 billion and a net profit of $10 million. In comparison, last year the company earned a revenue of $100.81 billion and had a net profit of $5.54 billion

Read More on UNH:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).